Ammar Sabilarrohman
In a landmark shift for the global box office, the hierarchy of biographical films has been rewritten. Antoine Fuqua’s Michael, a sprawling cinematic exploration of the life and career of Michael Jackson, has officially surpassed Christopher Nolan’s Oppenheimer to become the highest-grossing biopic of all time. This transition marks a significant milestone in modern cinema, underscoring the enduring, global magnetism of the "King of Pop" even in an era where traditional theatrical metrics are increasingly volatile.
The Financial Milestone: A Global Phenomenon
As of this past weekend, Michael—which features a star-making turn by Jackson’s nephew, Jaafar Jackson—reached a staggering cumulative global gross of $977.4 million. This total edges past the $975.8 million benchmark set by Oppenheimer in 2023.
The achievement is particularly notable given the current landscape of the industry. While the weekend headlines were largely preoccupied with the underwhelming opening of Supergirl, Michael quietly cemented its status in the record books during its 10th week of release. The film pulled in approximately $905,000 domestically over the weekend, bolstered by a robust $8.2 million from international territories. This brings its domestic haul to $370.2 million, complemented by an impressive $607.2 million from overseas markets.
By eclipsing Oppenheimer, Michael has now set its sights on a new, elite tier: the $1 billion club. Should it maintain its current momentum, it is poised to become only the second Hollywood release of 2026 to cross that threshold, following the success of The Super Mario Galaxy Movie.
Chronology of Success: From ‘Bohemian Rhapsody’ to ‘Oppenheimer’
To understand the gravity of this record, one must look at the evolution of the "musical biopic" and the "historical drama" as box office juggernauts. For years, the gold standard for musical biopics was 2018’s Bohemian Rhapsody, which grossed roughly $910 million worldwide. That film transformed the sub-genre into a lucrative tentpole model, proving that audiences were hungry for high-production-value narratives centered on global music icons.
In 2023, Christopher Nolan’s Oppenheimer redefined the potential for non-musical biopics. A dense, three-hour historical epic about the "father of the atomic bomb," it was widely considered a risky proposition for a $100 million budget. However, the "Barbenheimer" phenomenon—the cultural collision with Greta Gerwig’s Barbie—propelled the film to heights few analysts predicted. It not only became the highest-grossing biopic of all time but also secured the Best Picture Oscar, a rarity for a summer blockbuster.
Michael entered the fray with a different set of expectations. While Oppenheimer relied on prestige and critical acclaim, Michael leaned on the massive, multi-generational fandom of Michael Jackson. By surpassing Bohemian Rhapsody earlier in its run, it signaled its dominance in the musical space; by now toppling Oppenheimer, it has effectively transcended genre limitations to become the undisputed champion of the biographical form.
Supporting Data and Production Context
The journey of Michael to the top of the charts was far from straightforward. The film faced significant turbulence during its production phase, most notably the controversial decision to reshoot the entire third act. Sources indicate that these changes were spurred by the complex legal landscape surrounding the Jackson estate, particularly in the wake of settlements involving historical allegations of misconduct against the pop icon.
These production hurdles caused the film’s budget to balloon to upwards of $200 million. For a studio like Lionsgate, which lacks the diversified corporate cushion of giants like Disney or Warner Bros., this was a monumental financial gamble. The pressure on the film to perform was immense, as a failure of this magnitude would have posed an existential threat to the studio’s fiscal health.
However, the international market acted as the film’s primary engine. Jackson’s appeal remains unparalleled in regions like Asia, Europe, and Latin America, where the film’s performance outperformed domestic projections. This global hunger for the "Michael" narrative effectively de-risked the investment, turning a precarious production into a historic financial success.
Official Responses and Industry Perspectives
While the numbers are definitive, the film’s critical reception remains polarized. Unlike Oppenheimer, which was universally hailed as a masterpiece of craft and acting, Michael has faced lukewarm reviews from critics who argue that the film glosses over the more contentious aspects of the subject’s life.
Industry analysts have been quick to point out that box office dominance does not necessarily equate to critical consensus. "The audience for a Michael Jackson biopic is global and built-in," says one veteran analyst. "It’s a different kind of success than Oppenheimer. One was a cultural movement driven by critical prestige and the power of a director’s vision; the other is a massive, fan-driven event that taps into the mythos of the most famous entertainer in history."
Representatives for Lionsgate have largely focused on the record-breaking nature of the run, emphasizing the work of Antoine Fuqua and Jaafar Jackson. The studio is reportedly already in the planning stages for a sequel, which would focus on the later years of Jackson’s life.
Implications: What This Means for Hollywood
The success of Michael carries several significant implications for the future of the film industry:
1. The Power of the "Icon"
Hollywood studios are likely to double down on biographical films centered on globally recognized musical legends. We can expect an influx of "prestige-lite" biopics that focus on high production values, musical nostalgia, and a massive international rollout strategy. The "biopic-as-blockbuster" model is now a proven commodity.
2. Risk vs. Reward in Mid-Tier Studios
Lionsgate’s gamble serves as a case study for mid-sized studios. By betting big on a singular, high-profile project, they were able to secure a seat at the table alongside the "Big Five" distributors. This may embolden other independent or mid-tier studios to take similar risks on singular, tentpole-style biopics rather than attempting to build traditional franchises.
3. The Shift in Critical Influence
The fact that Michael has become the highest-grossing biopic despite mixed critical reviews suggests a widening gap between critic consensus and commercial success. In an age of social media, the "fan experience" and the appeal of the subject matter are increasingly overriding the traditional gatekeeping power of film critics.
4. The Future of the Jackson Franchise
The announcement of a potential sequel raises questions about the creative integrity of the biopic as a business model. While Oppenheimer stood as a singular, closed narrative, Michael is being positioned as a franchise. This suggests that Hollywood sees the "biopic" not just as a one-time historical record, but as a recurring intellectual property (IP).
Conclusion
The ascent of Michael to the top of the box office hierarchy is a testament to the enduring power of Michael Jackson’s legacy and the changing tides of the movie business. While Oppenheimer remains a landmark in terms of cinematic craft and critical reception, Michael stands as a titan of commercial reach.
As the film continues its theatrical run, it will likely serve as the blueprint for future studios looking to capture the "lightning in a bottle" that is the life story of a cultural icon. Whether this trend toward "biopic-franchising" will lead to meaningful storytelling or merely profitable exploitation remains to be seen. For now, however, the history books have been updated: the King of Pop has moonwalked into the top spot, leaving the world of cinema to grapple with the new rules of the game.
Layla Zulfa
Nana Wu
